PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Clinical trials for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested to ease strain on the heart in lung disease
Disease control Recruiting nowThis study is testing an oral medication called ROC-101 for adults with two types of high blood pressure in the lungs (pulmonary hypertension). About 40 participants will take the drug along with their standard care for 24 weeks to see if it is safe and if it helps improve how th…
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated Apr 04, 2026 02:51 UTC
-
Lifeline extended for patients in lung disease drug trial
Disease control AVAILABLEThis study provides continued access to an inhaled medication called TPIP for people with serious lung and heart conditions. It is for patients who have already successfully completed earlier long-term studies of this drug. The goal is to allow these patients to keep receiving a …
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC